D-0940-2023 Class II Terminated
FDA drug recall D-0940-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jul 13, 2023 and is designated Class II. Reason for recall: Presence of Foreign Substance: Metal embedded in a tablet. The recall status is terminated (terminated Feb 12, 2024). Affected quantity: 7313 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 2, 2023
- Initiation Date
- Jul 13, 2023
- Termination Date
- Feb 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7313 bottles
Product description
Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88.
Reason for recall
Presence of Foreign Substance: Metal embedded in a tablet.
Distribution pattern
Nationwide
Code information
Lot AC74459, Exp 07/31/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0940-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026